Sofinnova Investments’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
Other funds holding ALNY
Sofinnova Investments's ALNY Position: Q3 2026 in Review
Sofinnova Investments opened a new position in Alnylam Pharmaceuticals (ALNY) in Q3 2026: 112,879 shares worth $27.9M. The stake represents 1.21% of the portfolio and ranks #21 among its holdings. This is a return to the name: Sofinnova Investments previously reported a position in ALNY as recently as Q1 2025.
Sofinnova Investments first reported a position in ALNY in Q1 2019 and has held it in 9 quarters since. The position peaked at $47.6M in Q1 2025. 720 funds tracked by Wall St. Rank hold ALNY as of Q3 2026.
- Sofinnova Investments held 112,879 shares of Alnylam Pharmaceuticals worth $27.9M as of Q3 2026.
- Alnylam Pharmaceuticals was a new Sofinnova Investments position in Q3 2026.
- Alnylam Pharmaceuticals made up 1.21% of Sofinnova Investments's portfolio in Q3 2026, its #21 holding.
- Sofinnova Investments first reported a position in Alnylam Pharmaceuticals in Q1 2019 and has held it in 9 quarters since.
- Sofinnova Investments's Alnylam Pharmaceuticals position peaked at $47.6M in Q1 2025.
- 720 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q3 2026.
Based on Sofinnova Investments's 13F filing for Q3 2026, filed 16 Nov 2026.